Comparison of Two Intermittent Urinary Catheters
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01284361 |
|
Recruitment Status :
Completed
First Posted : January 27, 2011
Results First Posted : December 1, 2016
Last Update Posted : February 1, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Urinary Retention | Device: 30 cm Intermittent Catheter Device: 40 cm Intermittent Catheter | Not Applicable |
- is male and at least 18 years of age.
- is self-catheterizing at least 3 times a day.
- has been performing catheterizations for at least 2 months.
- is wheelchair bound.
- is able to use a size 12 or 14 French straight catheter.
- is willing and able to follow the study protocol and Investigator's instructions.
- is in the opinion of the Investigator, qualified to participate.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 91 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | None (Open Label) |
| Official Title: | User Preference Study to Compare a 40cm Intermittent Catheter to a 30cm Intermittent Catheter |
| Study Start Date : | October 2010 |
| Actual Primary Completion Date : | August 2011 |
| Actual Study Completion Date : | August 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: 30 cm Intermittent Catheter
Intervention was the test of a 30 cm catheter compared to standard commercial 40 cm catheter in a cross-over design.
|
Device: 30 cm Intermittent Catheter
Randomized cross-over
Other Name: Apogee Intermittent Catheter |
|
Active Comparator: 40 cm Intermittent Catheter
Active comparator 40 cm commercial catheter was compared to experimental 30 cm catheter in a cross-over design.
|
Device: 40 cm Intermittent Catheter
randomized cross-over
Other Name: Apogee Intermittent Catheter |
- Percentage of Participants [ Time Frame: 1 week ]Percentage of participants that preferred the 40 cm catheter
- Assessment of Ease of Use Characteristics [ Time Frame: 1 week ]Ease of insertion, removal, and control while catheterizing were assessed using a 5 point Likert scale. The numbers recorded are the percentage of the "top" two responses on a 5 point Likert scale. On one scale this includes 1) Very Easy or 2) Easy, on a scale ranging from 1) Very Easy to 5) Very Difficult. On the other scale this includes 1) Strongly Agree or 2) Agree on a scale ranging from 1) Strongly Agree to 5) Strongly Disagree.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- is male and at least 18 years of age
- is self-catheterizing at least 3 times a day
- has been performing catheterizations for at least 2 months
- wheelchair bound
- is able to use a size 12 or 14 French straight catheter
- is willing and able to follow the study protocol and Investigator's instructions
- is, in the opinion of the Investigator, qualified to participate
Exclusion Criteria:
- has cognitive impairments that preclude completion of study protocol
- cannot communicate as determined by the Investigator
- has an existing medical condition that, in the opinion of the investigator, would interfere with the subject's ability to participate or in the interpretation of the results
- has a symptomatic urinary tract infection determined by interview
- has a retracted penis
- has participated in a study during the previous 30 days involving catheterization
- has been diagnosed with an enlarged prostate
- has urethral strictures, false passages, or urethral obstruction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01284361
| United States, Georgia | |
| Shepherd Center and Crawford Research Institute | |
| Atlanta, Georgia, United States, 30309-1465 | |
| United States, Illinois | |
| Mark Drug Medical Supply | |
| Wheeling, Illinois, United States, 60090 | |
| United States, Missouri | |
| Restored Images | |
| Kansas City, Missouri, United States, 64119 | |
| United States, Tennessee | |
| Vanderbilt University | |
| Nashville, Tennessee, United States, 37235 | |
| Study Director: | Rita Kaurs, MSHSA MT NMT | Hollister Incorporated |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Hollister Incorporated |
| ClinicalTrials.gov Identifier: | NCT01284361 |
| Other Study ID Numbers: |
4875-I |
| First Posted: | January 27, 2011 Key Record Dates |
| Results First Posted: | December 1, 2016 |
| Last Update Posted: | February 1, 2017 |
| Last Verified: | December 2016 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | Published in Spinal Cord (2013) 51, 772-775 |
|
intermittent catheter preference |
|
Urinary Retention Urination Disorders Urologic Diseases |

